Cargando…

Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes

BACKGROUND: Greater efforts are needed to overcome the worldwide reported low achievement of LDL-c targets. This survey aimed to dissect whether and how the physician-based evaluation of patients with diabetes is associated with the achievement of LDL-c targets. METHODS: This cross-sectional self-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morieri, Mario Luca, Lamacchia, Olga, Manzato, Enzo, Giaccari, Andrea, Avogardo, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044595/ https://www.ncbi.nlm.nih.gov/pubmed/35473579 http://dx.doi.org/10.1186/s12933-022-01495-8

Ejemplares similares

Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
por: Morieri, Mario Luca, et al.
Publicado: (2022)

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics
por: Morieri, Mario Luca, et al.
Publicado: (2020)

Misperceiving and misreporting input quality: Implications for input use and productivity
por: Wossen, Tesfamicheal, et al.
Publicado: (2022)

Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes
por: Morieri, Mario Luca, et al.
Publicado: (2021)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Dealing with false positive risk as an indicator of misperceived effectiveness of conservation interventions
por: Khorozyan, Igor
Publicado: (2021)

Primary Ovarian Mucinous Adenocarcinoma, Expansile Type, Misperceived As Pregnancy by the Patient
por: Ortiz, Christina, et al.
Publicado: (2023)

Phytosterols, Cholesterol Control, and Cardiovascular Disease
por: Poli, Andrea, et al.
Publicado: (2021)

Misperceiving Bullshit as Profound Is Associated with Favorable Views of Cruz, Rubio, Trump and Conservatism
por: Pfattheicher, Stefan, et al.
Publicado: (2016)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Physicians’ behavior following changes in LDL cholesterol target goals
por: Vinker, Shlomo, et al.
Publicado: (2015)

Nonadherence, Clinical Inertia, or Therapeutic Inertia?
por: Allen, J. Daniel, et al.
Publicado: (2009)

Can we achieve ESC 2019 guidelines LDL-cholesterol target in Tunisia?
por: Ibn Elhadj, Zied, et al.
Publicado: (2022)

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)
por: Langslet, Gisle, et al.
Publicado: (2020)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
por: Storey, Benjamin C., et al.
Publicado: (2018)

Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
por: Chary, Abdolreza, et al.
Publicado: (2023)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
por: Silbernagel, Günther, et al.
Publicado: (2022)

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
por: Sangsawang, Tamon, et al.
Publicado: (2015)

Statin Intensity or Achieved LDL? Practice-based Evidence for the Evaluation of New Cholesterol Treatment Guidelines
por: Ross, Elsie Gyang, et al.
Publicado: (2016)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

Friedewald’s equation for calculating LDL-cholesterol: Is it the time to say “Goodbye” and adopt direct LDL cholesterol methods?
por: Khan, Sikandar Hayat, et al.
Publicado: (2019)

The Role of Cumulative LDL Cholesterol in Cardiovascular Disease Development in Patients with Familial Hypercholesterolemia
por: Korneva, Victoria, et al.
Publicado: (2022)

Nurse-coordinated care improves the achievement of LDL cholesterol targets through more intensive medication titration
por: Snaterse, Marjolein, et al.
Publicado: (2017)

Fat-to-Muscle Ratios and the Non-Achievement of LDL Cholesterol Targets: Analysis of the Korean Genome and Epidemiology Study
por: Cho, A-Ra, et al.
Publicado: (2021)

Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta‐Analysis
por: Zhang, Xin‐Lin, et al.
Publicado: (2019)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population
por: Nantsupawat, Nopakoon, et al.
Publicado: (2019)

Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
por: Khunti, Sachin, et al.
Publicado: (2019)

Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients
por: Karalis, Dean G., et al.
Publicado: (2012)

Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
por: Laufs, Ulrich, et al.
Publicado: (2016)

Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics
por: Youk, Tae Mi, et al.
Publicado: (2020)

General practitioners’ justifications for therapeutic inertia in cardiovascular prevention: an empirically grounded typology
por: Lebeau, Jean-Pierre, et al.
Publicado: (2016)

Secondary prevention and follow-up of patients with ACS and not-at-target LDL: An Italian real-world retro-prospective analysis by the inertia group
por: Del Pinto, Maurizio, et al.
Publicado: (2023)

Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain
por: Almusalam, Noora, et al.
Publicado: (2019)

Gravitation and inertia
por: Ciufolini, Ignazio, et al.
Publicado: (1995)

Cellular inertia
por: Ishiwata, Ryosuke, et al.
Publicado: (2021)

Misperceived pre-pregnancy body weight status predicts excessive gestational weight gain: findings from a US cohort study
por: Herring, Sharon J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_30a1or027j47m8dh9ub34s4taa